1. Home
  2. ROL vs ILMN Comparison

ROL vs ILMN Comparison

Compare ROL & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rollins Inc.

ROL

Rollins Inc.

N/A

Current Price

$38.06

Market Cap

18.5B

Sector

Finance

ML Signal

N/A

Logo Illumina Inc.

ILMN

Illumina Inc.

N/A

Current Price

$208.99

Market Cap

37.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ROL
ILMN
Founded
1948
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
37.0B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
ROL
ILMN
Price
$38.06
$208.99
Analyst Decision
Buy
Buy
Analyst Count
19
21
Target Price
$38.24
★ $261.45
AVG Volume (30 Days)
★ 6.9M
2.2M
Earning Date
10-21-2026
10-29-2026
Dividend Yield
★ 2.08%
N/A
EPS Growth
13.54
★ 170.87
EPS
0.85
★ 3.65
Revenue
$2,161,220,000.00
★ $4,343,000,000.00
Revenue This Year
$7.53
$6.61
Revenue Next Year
$7.29
$7.00
P/E Ratio
★ $45.11
$58.97
Revenue Growth
★ 7.23
N/A
52 Week Low
$29.29
$112.65
52 Week High
$66.14
$309.35

Technical Indicators

Market Signals
Indicator
ROL
ILMN
Relative Strength Index (RSI) 65.18 35.75
Support Level $36.21 $200.01
Resistance Level $39.51 $231.81
Average True Range (ATR) 1.08 14.04
MACD 0.28 -5.76
Stochastic Oscillator 77.70 12.08

Price Performance

Historical Comparison
ROL
ILMN

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: